Patents by Inventor Michael S. Lan

Michael S. Lan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10871306
    Abstract: A drain pan for a HVAC system includes a middle section defining a cavity extending from a first end of the middle section to a second end of the middle section, a first end section configured to partially extend into the cavity via the first end of the middle section, and a second end section configured to partially extend into the cavity via the second end of the middle section. The second end section includes a drain port. In some embodiments, the drain pan is modular, enabling different middle sections of various lengths to be coupled between the end sections. The cavity of some embodiments is formed by double walls, which insulate the middle section to reduce condensate formation on a bottom surface of the middle section. By forming one or multiple sections from plastic with an anti-microbial additive, the drain pan further reduces corrosion, microbial growth, and/or condensate generation.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: December 22, 2020
    Assignee: Johnson Controls Technology Company
    Inventors: Michael S. Lanning, Christian C. Herbeck, Jeremy S. Morris, Joshua J. Yagy
  • Publication number: 20200208872
    Abstract: A drain pan for a HVAC system includes a middle section defining a cavity extending from a first end of the middle section to a second end of the middle section, a first end section configured to partially extend into the cavity via the first end of the middle section, and a second end section configured to partially extend into the cavity via the second end of the middle section. The second end section includes a drain port. In some embodiments, the drain pan is modular, enabling different middle sections of various lengths to be coupled between the end sections. The cavity of some embodiments is formed by double walls, which insulate the middle section to reduce condensate formation on a bottom surface of the middle section. By forming one or multiple sections from plastic with an anti-microbial additive, the drain pan further reduces corrosion, microbial growth, and/or condensate generation.
    Type: Application
    Filed: January 16, 2019
    Publication date: July 2, 2020
    Inventors: Michael S. Lanning, Christian C. Herbeck, Jeremy S. Morris, Joshua J. Yagy
  • Patent number: 9090907
    Abstract: A modification of the existing INSM1 promoter region has been discovered that incorporated DNA elements that silence expression of neuronal genes in non-neuronal cells and that has increased the effectiveness and safety of using the INSM1 promoter for tumor treatment. One modification was addition of one or two tandem copies of neuronal restrictive silencer elements (NRSEs) derived either from the mouse nicotinic acetylcholine receptor (nAChR) or the rat superior cervical ganglion 10 (SCG10) promoters. These NRSEs were placed in the expression construct either directly upstream or downstream of the INSM1 promoter sequence. The most effective expression construct was the nAChR NRSE element positioned downstream of the INSM1 promoter. This expression construct increased the tissue specificity of the INSM1 promoter without a significant decrease in its activity. In addition, the modified INSM1 promoter was placed into a viral vector, adenovirus 5.
    Type: Grant
    Filed: November 8, 2010
    Date of Patent: July 28, 2015
    Assignee: Board of Supervisors of Louisiana State University And Agricultural and Mechanical College
    Inventors: Mary B. Breslin, Michael S. Lan
  • Publication number: 20120316225
    Abstract: A modification of the existing INSM1 promoter region has been discovered that incorporated DNA elements that silence expression of neuronal genes in non-neuronal cells and that has increased the effectiveness and safety of using the INSM1 promoter for tumor treatment. One modification was addition of one or two tandem copies of neuronal restrictive silencer elements (NRSEs) derived either from the mouse nicotinic acetylcholine receptor (nAChR) or the rat superior cervical ganglion 10 (SCG10) promoters. These NRSEs were placed in the expression construct either directly upstream or downstream of the INSM1 promoter sequence. The most effective expression construct was the nAChR NRSE element positioned downstream of the INSM1 promoter. This expression construct increased the tissue specificity of the INSM1 promoter without a significant decrease in its activity. In addition, the modified INSM1 promoter was placed into a viral vector, adenovirus 5.
    Type: Application
    Filed: November 8, 2010
    Publication date: December 13, 2012
    Inventors: Mary B. Breslin, Michael S. Lan
  • Patent number: 6391651
    Abstract: The method and compositions of this invention provide an effective and reliable substitute for the currently employed ICA assay for diabetes. By providing a method for detecting autoantibodies to both GAD65 and IA-2 auto-antigens, the method provides a chemical assay which has improved reliability. In addition, these antigens may be employed in therapeutic regimens aimed at achieving immune tolerance and therefore amelioration of the clinical condition.
    Type: Grant
    Filed: August 11, 1995
    Date of Patent: May 21, 2002
    Assignees: The United States of America as represented by the Secretary of the Department of Health & Human Services, University of Florida
    Inventors: Noel K. Maclaren, Abner L. Notkins, Michael S. Lan
  • Patent number: 6225049
    Abstract: A novel insulinoma-associated, neuroendocrine tumor-associated cDNA sequence is disclosed. The sequence and fragments thereof are useful for the diagnosis and identification of insulinoma and neuroendocrine tumors. The invention relates to a method for identifying a cancer employing the insulinoma-associated nucleic acid, polypeptide and antibody generated thereto.
    Type: Grant
    Filed: May 19, 1994
    Date of Patent: May 1, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Michael S. Lan, Abner L. Notkins
  • Patent number: 5989551
    Abstract: The method and compositions of this invention provide an effective and reliable substitute for the currently employed ICA assay for diabetes. By providing a method for detecting autoantibodies to GAD.sub.65, IA-2 and a previously unidentified antigen termed IA-2.beta. herein, the method provides a chemical assay which has improved reliability. In addition, these antigens may be employed in therapeutic regimens aimed at achieving amelioration of the clinical condition.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: November 23, 1999
    Assignees: The United States of America as represented by the Department of Health and Human Services, The University of Florida
    Inventors: Noel K. Maclaren, Abner L. Notkins, Michael S. Lan, Qing Li